Navigation Links
A New Anti-Cancer Drug Keeps Resistance Out

An experimental drug named Dasatinib, developed by Bristol-Myers Squibb company offers a valuable treatment against the signs and symptoms of chronic myeloid leukemia// patients than the usual drug named Gleevec.

Patients, who are resistant to Gleevec drug can now be treated with dasatinib, which seems to regulate intolerance and complications of chronic myeloid leukemic patients - studies published in NEJM finds.

In the phase I clinical trials dasatinib overcome Gleevec resistance in about 68 of 84 patients studied - study leader, HHMI investigator Charles L. Sawyers, and colleagues at UCLA's Jonsson Comprehensive Cancer Center, reported.

People in all 3 stages of the disease such as chronic phase, the accelerated phase, and blast crisis respond to the new drug quite possibly, Sawyers says.

Sawyers said, ‘Drug-related mutations are better understood by the application of experimental drug, dasatinib to subjects and even individual patient’s mutation type were easily studied by scientists at Bristol-Myers Squibb’.

‘How drug target mutation take place and whether molecular explanation of drugs has any role to play in it’ all studied by the scientists, showing improvements in structural biology studies.

Due to being as a ‘sloppier inhibitor’ meaning - does not hold its target to such tight structural constraints, dasatinib differs from the drug Gleevec.

Sawyers added dasatinib proves its value to overcome kinase resistance in managing cancer patients and also keep rooting in other fields of medicine like molecular oncology and structural biology.

Page: 1

Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. FDA Approves Anti-Cancer Cell Drug - Zevalin
3. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
4. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
5. Antidepressant Drug Found To Have Anti-Cancer Effects
6. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Exercise Has An Anti-Cancer Effect
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:

(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, an online ... of its new Professional Medical Coding and Billing with Applied PCS career training ... ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified Coding Associate ...
(Date:10/12/2015)... , ... October 12, 2015 , ... ... August 19, 2015, high school aged female athletes, particularly in the area of ... repetitive motion and mechanical overuse injuries than male peers in the same age ...
(Date:10/12/2015)... Los Angeles, CA (PRWEB) , ... October 12, 2015 , ... ... 7th, the Fire Chief for the city of San Antonio, Texas recommended that any ... retrofitted to incorporate these important safety systems going forward. The article explains that it ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, ... Cleveland Clinic in honor of Breast Cancer Awareness Month. During the month ... will donate a SleepPhones® Classic product to a breast cancer patient at the ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... On July ... MN. Their mission: To paddle the entire 2,320-miles of river to the Gulf of ... halfway done with the monumental journey, with two months remaining for a November 22nd ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... October 12, 2015 ... to grow at 7.2% CAGR, microscopy market ... rising focus on nanotechnology, technological advancements, and ... report available with ... . --> Complete report on ...
(Date:10/12/2015)...   Royal Philips (NYSE: PHG, AEX: PHIA), ... a collaboration with Genomic Health , Inc. (NASDAQ: ... diagnostic tests, to leverage Philips digital pathology tools in ... testing processes.    --> ... samples and plays a crucial role in the diagnosis ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: ... District of Delaware granted the Company,s ... Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to market ... (buprenorphine and naloxone) Sublingual Film (CIII) in the ... --> Since August 2013, Indivior has received Paragraph IV ...
Breaking Medicine Technology: